Novel approach to quantitative analysis of bisphosphonates in human urine and serum by HPLC-tandem mass spectrometry

ANYL 347

Lee S. Zhu, lee.zhu@mdsps.com1, Veni Lapko1, Yousef Basir1, Chris Kafonek1, Richard Olsen1, Chad Briscoe1, and Jean W. Lee2. (1) Bioanalysis, MDS Pharma Services, 621 Rose Street, Lincoln, NE 68502, (2) Amgen Inc, One Amgen Center Drive, Thousand Oaks, CA 91320
Bisphosphonates with P-C-P structure are broadly studied for the treatment of born diseases. These compounds are extremely hydrophilic with bioanalytical challenges in sample extraction and analytes detection. An approach to achieve highly sensitive and selective quantative analysis of bisphosphonates in human urine and serum by LC-MS/MS is present here. The novelty is a direct on-column derivatization with diazomethane during the solid phase extraction (SPE). The reproducible methylation the bisphosphonate group enabled a greatly simplified purification procedure. The derivatized anylates are rendered high signal to noise ratio in the Electrospray Ionization (ESI) Mass Spectrometer. A low limit of quantitation (LLOQ) at pictogram/mL can be easily achieved using only 100-200mL of sample.